Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Clinical trial NCT00469729 · COMPLETED
Trial details
- NCT number
- NCT00469729
- Sponsor
- Gamida Cell -Teva Joint Venture Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.